Spore.Bio,一家利用机器学习技术检测工厂病原体的初创公司,宣布已筹集800万欧元的Pre-seed轮融资。该公司建造了世界上第一台直接在工厂车间立即检测病原体的设备,使用先进的机器学习模型来训练其系统,以识别食品、饮料、药品和化妆品中的细菌浓度,然后提醒质量经理潜在风险。
Spore.Bio的创始人表示,这笔融资将用于进一步开发其技术,扩大检测范围,并拓展全球市场。该公司已经在欧洲和北美市场取得了不错的业绩,计划在未来一年内进入亚洲市场。
Tech.eu认为,Spore.Bio的技术有望成为解决全球快速消费品(FMCG)市场关键健康和安全挑战的重要工具。
新闻翻译：
Headline: Spore.Bio, factory pathogen detection startup, raises 8 million euros in pre-seed round financing
Keywords: factory pathogen, detection, financing, Spore.Bio
News content:
Spore.Bio, a startup that uses machine learning technology to detect pathogens in factories, has announced that it has raised 8 million euros in pre-seed round financing. The company has built the world’s first device for pathogen detection in real-time in the factory, using advanced machine learning models to train its system to identify the concentration of bacteria in food, beverages, pharmaceuticals, and cosmetics. The system then alerts quality managers of potential risks.
Spore.Bio’s founders said the financing will be used to further develop its technology, expand detection scope, and expand into global markets. The company has already achieved promising results in the European and North American markets and plans to enter the Asian market next year.
Tech.eu believes that Spore.Bio’s technology has the potential to become an important tool for addressing key health and safety challenges in the global fast-consumer market (FMCG).
【来源】https://tech.eu/2023/12/12/sporebio-raises-eur8m-for-real-time-pathogen-detection-in-fmcg-factories/
Views: 1